Effect of hormone therapy on breast epithelial cell proliferation

Menopause

Volumn 20, Issue 5, 2013, Pages 483-485

  Stanczyk, Frank Z ^a   Winer, Sharon A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CONJUGATED ESTROGEN; DIENOGEST PLUS ESTRADIOL VALERATE; ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTROGEN RECEPTOR; ESTRONE; ETHINYLESTRADIOL; GESTAGEN; MEDROXYPROGESTERONE ACETATE; PROGESTERONE RECEPTOR; TIBOLONE;

BREAST BIOPSY; BREAST CARCINOMA; BREAST CELL; CANCER RISK; CELL PROLIFERATION; EDITORIAL; EPITHELIUM CELL; EPITHELIUM HYPERPLASIA; ESTRADIOL BLOOD LEVEL; ESTRONE BLOOD LEVEL; FINE NEEDLE ASPIRATION BIOPSY; FOLLICULAR PHASE; HORMONAL THERAPY; HORMONE DETERMINATION; HUMAN; LUTEAL PHASE; PHENOTYPE; POSTMENOPAUSE; THERAPY EFFECT; UPREGULATION;

BREAST; CONTRACEPTIVES, ORAL, SYNTHETIC; ESTRADIOL; ESTROGENS; FEMALE; HUMANS; NORETHINDRONE; POSTMENOPAUSE;

EID: 84879207102     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e31828ebfb6     Document Type: Editorial

References (14)

1. Wellings SR. A hypothesis of the origin of human breast cancer from the terminal ductal lobular unit. Pathol Res Pract 1980; 166:515-535.
2. Preston-Martin S., Pike MC, Ross R.K., Jones PA, Henderson BE Increased cell division as a cause of human cancer. Cancer Res 1990; 50: 7415-7421.
3. Spicer DV, Pike MC Other hormonal prevention strategies. In: Henderson BE, Ponder B, Ross RK, eds. Hormones, Genes and Cancer. New York, NY: Oxford University Press Inc., 2003:248-254.
4. Navarrete MA, Maier CM, Falzoni R, et al Assessment of the prolifer-ative, apoptotic and cellular renovation indices of the human mammary epithelium during the follicular and luteal phases of the menstrual cycle. Breast Cancer Res 2005; 7:R306-R313.
5. Pike MC, Spicer DV, Dahmoush L, Press MF Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993; 15:17-35.
6. Hofseth LJ, Raafat AM, Osuch J.R., Pathak DR, Slomski CA, Haslam SZ Hormone replacement therapy with estrogen or estrogen plus medroxy-progesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. J Clin Endocrinol Metab 1999; 84:4559-4565.
7. Conner P, Söderqvist G, Skoog L., et al Breast cell proliferation in postmenopausal women during HRT evaluated through fine needle aspiration cytology. Breast Cancer Res Treat 2003; 78:159-165.
8. Valdivia I, Campodónico I, Tapia A., Capetillo M, Espinoza A, Lavín P. Effects of tibolone and continuous combined hormone therapy on mam-mographic breast density and breast histochemical markers in postmeno-pausal women. Fertil Steril 2004; 81:617-623.
9. Cheng G, Butler R, Warner M., Gustafsson JA, Wilczek B, Landren BM Effects of short-term estradiol and norethindrone acetate treatment on the breasts of normal postmenopausal women. Menopause 2013; 20:496-503.
10. Stanczyk FZ, Hapgood JP, Winer S, Mishell DR Jr. Progestogens used in postmenopausal hormone therapy: differences in their pharmaco-logical properties, intracellular actions, and clinical effects. Endocr Rev 2013; in press.
11. Kuhnz W, Heuner A, Hümpel M, Seifert W., Michaelis K. In vivo conversion of norethisterone and norethisterone acetate to ethinyl estradiol in postmenopausal women. Contraception 1997; 56:379-385.
12. Chu MC, Zhang X, Gentzschein E., Stanczyk FZ, Lobo RA Formation of ethinyl estradiol in women during treatment with norethindrone acetate. J Clin Endocrinol Metab 2007; 92:2205-2207.
13. McGuire WL, Clark GM The prognostic role of progesterone receptors in human breast cancer. Semin Oncol 1983; 10:2-6.
14. Sunderland MC, McGuire WL Hormones and breast cancer. Trends Endocrinol Metab 1991; 2:72-76.